Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:providence_therapeutics [2022/07/12 15:47]
liam [COVID-19]
+++ pharmaceutical_companies:providence_therapeutics [2023/05/11 07:12] (current)
liam
@@ Line 15: / Line 15: @@
 One year later in April 2021, Providence founder [[:Brad Sorenson]] announced he was fed up with the lack of support from the Canadian government and would be relocating operations overseas.((Tasker, J. P. (2021, April 30). //COVID-19 vaccine maker Providence says it’s leaving Canada after calls for more federal support go unanswered.// CBC News. https://web.archive.org/web/20220711165025/https://www.cbc.ca/news/politics/providence-therapeutics-pulling-out-canada-1.6009068))
-On September 13, 2021, Providence announced that it had entered into two separate contracts with [[:Everest Medicines]] to license rights to their mRNA COVID-19 vaccine candidates to markets in [[:China]], Southeast [[:Asia]] and [[:Pakistan]].
+On September 13, 2021, Providence announced that it had entered into two separate contracts with [[:Everest Medicines]] to license rights to their mRNA COVID-19 vaccine candidates to markets in [[:China]], Southeast [[:Asia]] and [[:Pakistan]], and to establish a broader global partnership around the mRNA platform.((Forester, N., Wong, N., Robinson, D., & Lococo, E. (2021, September 13). //Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia.// Providence Therapeutics. https://providencetherapeutics.com/press-details/providence-therapeutics-enters-into-comprehensive-agreements-with-everest-medicines-to-advance-mrna-vaccines-and-therapies-including-covid-19-vaccines-in-emerging-markets-in-asia.html))
 ===== Affiliations =====
@@ Line 31: / Line 31: @@
 | [[:Eric Marcusson]]  | Co-founder & board member  | [[Isis Pharmaceuticals]], [[Regulus Therapeutics]]  |
 | [[:Donna T. Ward]]  | Board member  | [[Ionis Pharmaceuticals]], [[Alnylam Pharmaceuticals]], [[:DT Ward, PC]]  |
-| [[:Pam Ohashi]]  | Scientific Advisory Board chair  | [[:University of Toronto]], [[:Canada Research Chair]], [[:Princess Margaret Cancer Centre]], [[:American Association for Cancer Research]]  |
+| [[:Pamela Ohashi]]  | Scientific Advisory Board chair  | [[:University of Toronto]], [[:Canada Research Chair]], [[:Princess Margaret Cancer Centre]], [[:American Association for Cancer Research]]  |
 | [[:Brian Barber]]  | Scientific Advisory Board member  | [[:University of Toronto]], [[:University Health Network]], [[Sanofi Pasteur]], [[Mojave Therapeutics]]  |
 | [[:Art Krieg]]  | Scientific Advisory Board member  | [[Translate Bio]], [[Checkmate Pharmaceuticals]], [[Coley Pharmaceuticals]], [[Sarepta Pharmaceuticals]], [[Pfizer]], [[:Atlas Ventures]], [[:RNA Therapeutics Institute]] at the [[:University of Massachusetts]], [[:Oligonucleotide Therapy Society]]  |